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ABSTRACT
Background: Sporotrichosis is a dermatozoonosis that affects mammals in general, with the domestic feline (Felis catus) 
being the most epidemiologically important species. However, diagnosis of this disease in dogs is important considering 
the proximity with people and with other communicants. The epidemiology of sporotrichosis is already known in some 
states of Brazil, especially in the southeast region, but to the best of our knowledge there are no reports of sporotrichosis 
in non-human species in the state of Espírito Santo. This paper aimed at describing the first case of canine sporotrichosis 
in Espírito Santo, Brazil.
Case: A 10 year-old Bull Terrier male dog was presented with nodular non-ulcerated lesions on the head and nodular 
ulcerated lesion on the nasal planum. The dog had a previous diagnosis of a low-grade mast cell tumour and palpebral 
melanoma. Mast cell tumour was treated with scrotum ablation (and orchiectomy) and bilateral inguinal lymph node re-
moval, followed by chemotherapy with twelve intravenous infusion of vinblastine, along with prednisolone. Cutaneous 
lesions in the head and nasal planum appeared two months after finishing chemotherapy. At further anamnesis, the pet´s 
responsible reported that the dog had the habit of hunting cats that entered the residence, which raised the hypothesis of 
sporotrichosis. An undiagnostic cytology was performed, followed by a fungal culture, positive for Sporothrix schenckii. 
Treatment was then initiated with itraconazol (Oficial generic drug), at a dose of 10mg/kg/SID, until clinical remission, 
obtained after 60 days, maintaining it for 60 more days. Patient showed completed recovery, with no further complatints 
after a follow-up of more than 220 days. 
Discussion: Sporotrichosis is considered a rare disease in dogs, with isolated cases in the literature. The dog of the present 
report was diagnosed with sporotrichosis two months after the end of a chemotherapy treatment for a mast cell tumour. 
Therefore, it is suggested that the patient in this study was infected during an immunosuppressive phase. The same can 
occur with other immunosuppressive treatments, such as glucocorticoid, also included in the chemotherapy treatment 
of this patient, calcineurin inhibitors (cyclosporine) and mercaptopurine derivatives (azathioprine). Cytology is usually 
unconclusive for such lesions in dogs, once only a few yeast might be present. Nevertheless, the definitive diagnosis was 
obtained through fungal microculture. Treatment with itraconazol was successful but dogs might also present favorable 
responses to ioidine. Itraconazole is a fungistatic drug, fungicidal only in high doses. For this reason, if the fungistatic dose 
is not administered for sufficient time, recurrences may occur. In the last three years, the state of Espirito Santo has become 
a new epidemiological scenario for sporotrichosis, and it is placed in the route of transmission, closely to Rio de Janeiro. 
Cats are the most affected animals and are commonly responsible for transmission to other species, including humans. The 
increase in cases of canine sporotrichosis requires its inclusion in the differential diagnosis of nodular-ulcerative lesions, 
along with cutaneous neoplasias and immune-mediated diseases. 
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INTRODUCTION
Sporotrichosis is a fungal zoonosis highly 
prevalent in subtropical and tropical regions around 
the world, caused by the dimorphic fungi complex 
Sporothrix schenckii [1,4]. Transmission occurs through 
biting, scratching or contact with exsudates from lesions 
of diseased cats [4,13]. In Brazil, this dermatozoonosis 
has been described in Minas Gerais, São Paulo, Paraná, 
Rio Grande do Sul and Rio de Janeiro [8,13,16,17,19], 
nevertheless, in the state of Espírito Santo, it has only 
been reported in humans [9]. In the literature, there is a 
paucity of papers that mention transmission and ocur-
rence in cats and even fewer in dogs [4,13].
Heretofore six species has been described 
and related to clinical sporotrichosis: S. brasiliensis, 
S. globosa, S. luriei, S. mexicana, S. albicans and S. 
schenckii sensu stricto. Sporothrix species differs ac-
cording to its geographic distribution. Classically, the 
infection occurs through the traumatic implantation of 
the aetiologic agent in the dermis, through plant frag-
ments or soil organic matter contaminated by fungal 
propagules of Sporothrix sp. [12].
This article aims to make the first description of 
a case of canine sporotrichosis in the state of Espírito 
Santo, Brazil. In the present report attention is given 
to its clinical presentation, which can mimic bacterial, 
neoplastic or immunomediated diseases [9,13,18], but 
also to the fact that the patient’s immune system might 
be compromised due to a diagnosis of malignancy 
followed by surgery and adjuvant chemotherapy, 
shortly before sporotrichosis presentation. 
CASE 
A 10 year-old Bull Terrier male dog was sub-
mitted scrotum ablation (and orchiectomy) and bilateral 
inguinal lymph node removal, due to a mast cell tumour, 
diagnosed as grade I / low-grade, with clean margins on 
histopathology. At the same event a palpebral nodule 
was removed and diagnosed as a melanoma. The dog 
was submitted to 12 intravenous infusion of vinblastine 
(Velban®)1 [2 mg/m² - six sessions every seven days 
and the next six every 14 days], along with prednisolone 
(Alcort®)2 [40 mg/m2 every 24 h, during seven days, 
followed by 25 mg/m2, every 24 h, during 30 days and 
25 mg/m2 every 48 h, for 60 days]. 
Two months after finishing chemotherapy the 
dog presented with small non-ulcerated nodules on 
the head, and an ulcerated nodule in the nasal planum 
(Figure 1A-B). The dog was unsatisfactory treated 
with cephalexin (generic drug)3 [25 mg/kg every 12 
h], during 30 days, associated with topical application 
of gentamicin 0.5 g, sulfanilamide 5.0 g, sulfadiazine 
5.0 g, urea 5.0 g, vitamin A 120.000 UI, q.s.p 100.0g 
excipient (Vetaglós)4. At further anamnesis, the pet´s 
responsible reported that the dog had the habit of hunt-
ing cats that entered the residence, which raised the 
hypothesis of sporotrichosis. 
The following was then carried out with fine 
needle aspiration of the injuries in the head and nasal 
planum, for cytological evaluation and fungal culture. 
The cytology revealed individual or grouped polygonal 
and spindle cells, presenting fine cytoplasmic granula-
tion, marked anisocytosis and pleomorphism with high 
nuclei:cytoplasm ratio, binucleation, coarse chromatin 
and single nucleoli. There was no mitotic figures, but 
there was moderate count of neutrophils, plasma cells 
and macrophages, compatible with pyogranulomatous 
process associated to stroma activation. However, after 
30 days, the microculture technique detected hyaline 
septated hyphae with unicellular conidia stained with 
the lactophenol blue solution and compatible with 
Sporothrix schenckii (Figure 2). Punch biopsy was 
also performed and histopathology revealed multifocal 
orthokeratotic and parakeratotic hyperkeratosis, marked 
multifocal ulceration and discontinuation of the epider-
mis, moderate espongiosis and inflammatory infiltration 
composed by large numbers of neutrophils, macro-
phages, lymphocytes and plasma cells. A few, circular 
yeasts with negative imaging halo were rarely seen in 
the interstitium and interior of macrophages (Figure 3). 
Treatment was then initiated with itraconazol (generic 
drug)5 [10 mg/kg every 24 h] until clinical remission, 
obtained after 60 days, maintaining it for 30 more days. 
Patient showed completed recovery, with no further 
complatints through a follow-up of more than 220 days. 
DISCUSSION
Sporotrichosis is considered a rare disease in 
dogs, with isolated cases in the literature [18]. Howe-
ver, an increasing number of cases have been reported 
in Rio de Janeiro, associated with an epidemic outbreak 
in cats, from 1998 to 2009 [2,6,20]. In the present re-
port, contact with cats was deemed an important risk 
factor, detected in the anamnesis, which allowed the 
inclusion of sporotrichosis as a differential diagnosis 
for the presented lesions.
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In humans, most infections become apparent in 
1-3 weeks, however, the incubation period may reach 
three months [5,12]. The dog of the present report 
showed the first signs of sporotrichosis two months 
after the end of a chemotherapy treatment for a mast 
cell tumour, which despite the complete surgical ex-
cision and classification as a low grade, occurred in 
a location associated with poor prognosis (scrotum), 
which suggested the need for complementation [11]. 
Therefore, although it can not be proven, it is suggested 
that the patient in this study was infected during an 
immunosuppressive phase, as a relapse of pulmonary 
sporotrichosis reported in a 44-year-old American 
African man after treatment of an esophageal squa-
mous cell carcinoma with radiation therapy along with 
chemotherapy with carboplatin and paclitaxel [10]. 
The risk of infection during chemotherapy and soon 
after its completion is one of the critical and limiting 
points in cancer treatment, greatly affecting the ability 
of the host to develop an adequate fungicidal response 
Figure 1. A- Patient 30 days after initiating treatment protocol with Itraconazole 10 mg/kg/SID (white arrow). B- Remission of lesions beginning (yel-
low arrow).
Figure 2. Photomicrograph of microculture technique showing hyaline 
septated hyphae with unicellular conidia stained with the lactophenol 
blue solution and compatible with Sporothrix schenckii [Lactophebol blue 
solution, 100x]. 
Figure 3. Nasal planum ulcerated lesion on histopathology. Mixed inflam-
matory infiltrate with circular yeasts with negative imaging halo (arrow) 
[HE, 100x].
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due to the depletion of the immunity response [21-23]. 
Among other mechanisms, detrimental of innate res-
ponse is related to reduction of the number and func-
tion of neutrophils, monocytes, Natural Killers, whilst 
impairment in adaptive immunity is mainly related to 
lymphocyte depletion. The same can occur with other 
immunosuppressive treatments, such as glucocorticoid, 
also included in the chemotherapeutic treatment of 
this patient, calcineurin inhibitors (cyclosporine) and 
mercaptopurine derivatives (azathioprine) [3,14,15].
The patient presented small non-ulcerated no-
dules in the head region, and a nodule already ulcerated 
in the nasal plane, which had fast progression, according 
to the pet´s responsible. The immune status of the host, 
infective load, lesion depth and temperature resistance 
are important factors that influence the clinical pre-
sentation of the disease in dogs [4,5,13]. The nodular / 
ulcerative form of the lesions presented by the patient 
made it possible to include, among the differential diag-
noses, deep pyoderma, demodiciosis, dermatophytosis 
and sporotrichosis, but also immunomediated and 
neoplastic disease, including canine mast cell tumour 
itself, characterized by a wide lesion pleomorphism and 
heterogeneity in its biological behaviour [17].  
The cytology of the lesion was one of the 
requested tests, however it was non diagnostic for the 
fungal lesion, showing only inflammatory infiltrate and 
stroma activation. In dogs, it is common for lesions 
to contain few yeasts, reducing the sensitivity of the 
method, as for histopathology, although this method 
allowed yeast´s identification on this report [4,5,13,16]. 
However, after the collection and before the suspicion 
of sporotrichosis, it was essential to collect and send 
material for the fungal culture, considered the gold 
standard for its diagnosis [16]. On histopathological 
examination there was a few circular yeasts but elon-
gated forms were not seen, as those forms are rarely 
present in dogs with sporotrichosis [20].
The therapy instituted was based on itraconazo-
le at 10 mg/kg, every 24 h, obtaining a clinical cure wi-
thin 60 days, but maintaining the treatment for another 
60 days, as recommended. Yet, dogs usually presents 
favorable responses to iodide, at a dose of 20-40 mg/
kg every 8 or 12 h [8]. The literature reports success in 
the treatment of feline sporotrichosis using itraconazole 
at the dose of 5-10 mg/kg/day [17]. However, it should 
be mentioned that itraconazole is a drug primarily fun-
gistatic which may be fungicidal in high doses. For this 
reason, if the fungistatic dose is not administered for 
sufficient time, recurrences may occur [7].
In the last three years, Espírito Santo has 
become a new epidemiological scenario for sporotri-
chosis, but data have not yet been published [4,5,13]. 
Cats are the most affected animals and are commonly 
responsible for transmission to other species, including 
humans. However, this is the first non-human report 
in the state of Espírito Santo. The increase in cases 
of canine sporotrichosis requires its inclusion in the 
differential diagnosis of nodular-ulcerative lesions, 
along with cutaneous neoplasias and immune-mediated 
diseases. Fungal outburst should be included as a diffe-
rential diagnosis for cutaneous and nasal lesions during 
and after  cancer treatment. Moreover, considering 
the proximity of dogs and humans, and the zoonotic 
potential of sporotrichosis, attention should be paid to 
the diagnosis and correct treatment.
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